VR Exposure Therapy for Agoraphobia: The NHS gameChange Trial

Why Agoraphobia Demands Scalable Solutions

Agoraphobia is an anxiety disorder characterized by intense fear of situations from which escape would be difficult or embarrassing: public transportation, open spaces, crowded stores, crowds, or being alone outside the home. Its annual prevalence in the European adult population is around 1 percent, with a chronic course and a level of disability higher than that of many medical conditions.

The standard psychotherapeutic approach is cognitive-behavioral therapy with exposure, ideally in vivo. British NICE guidelines and European recommendations consider it a first-line intervention. In practice, however, access to treatment is uneven: long waiting lists in public systems, a shortage of psychologists trained in exposure, and patients’ reluctance to leave home to start sessions.

This mismatch between need and supply makes agoraphobia a paradigmatic case for digital innovations that reduce dependence on a therapist per session. VR is a natural candidate because it lets patients be exposed without leaving the office or their own home.

What gameChange Is and Why It Matters

gameChange is a VR exposure program designed by Daniel Freeman’s group at the University of Oxford. The key innovation isn’t the scenario itself but the format: the clinical guidance during the session is provided by an automated virtual coach, not an in-person psychologist.

The protocol combines brief initial psychoeducation, six structured VR exposure sessions, and a transfer phase to real-life situations. Each session lasts about half an hour, and a trained coach (not necessarily a psychologist) supports the patient technically and motivationally. The supervising psychologist steps in only for assessment, treatment indication, and complex cases.

This architecture shifts the treatment bottleneck: instead of requiring several hundred hours of an expert psychologist per patient, it requires several dozen hours of a trained coach plus limited psychological supervision. Scalability is what justifies the NHS’s interest.

Trial Design and Sample

The randomized controlled trial published in Lancet Psychiatry in 2022 included around 346 adult participants with psychosis and severe agoraphobia difficulties, recruited across five NHS services. Patients were assigned to standard treatment plus gameChange or standard treatment alone, with blind assessments at six weeks and 26 weeks.

The primary outcome measure was the Oxford Agoraphobic Avoidance Scale, complemented by instruments assessing general psychopathology and quality of life. Adherence to the VR protocol was high, above what is typical for in vivo exposure, and the proportion of completed sessions stayed notably strong throughout follow-up.

The most notable finding: the effect was larger in patients with greater initial severity — precisely the subpopulation that benefits most and that traditionally falls through the cracks of services. Improvement held at 26 weeks, suggesting consolidation of inhibitory learning.

The Automated Virtual Coach: How It Works

A distinctive feature of gameChange is the virtual coach who guides the patient through the immersion. It is a simplified conversational agent, not a generative artificial intelligence system, that follows a structured clinical script and provides contextual feedback (‘we’re going to bring you closer to the edge of this platform,’ ‘notice how no one is looking at you,’ ‘think back to what you expected and what actually happened’).

The script was designed by clinicians trained in CBT with prior experience in agoraphobia. The virtual coach doesn’t improvise: it delivers one of several dozen pre-designed lines depending on the stage of the protocol, the active scenario, and the SUDS data entered by the patient. This structure reduces reliance on in-the-moment clinical judgment and lets the accompanying human coach delegate technical guidance to the system.

It’s worth emphasizing that an automated virtual coach is not a substitute for the licensed psychologist: it complements their work on the repetitive exposure component. Clinical indication, case formulation, interim assessment, and protocol closure still require professional judgment. The operational lesson is that automating what can be automated frees up clinical time for what genuinely requires human judgment.

Operational Lessons for Private Practice in Spain

The study was carried out in a public system with trained coaches and limited psychological supervision. Transferring that logic to private practice in Spain requires adaptation, but the strategic direction is relevant. First, the psychologist doesn’t need to be present at every exposure session: once the protocol is established, a trained healthcare professional can run the technical session under supervision.

Second, the brief format (six intensive sessions) fits the type of protocol Spanish patients accept when they’re paying out of pocket. Third, combining it with standard treatment is viable: the psychologist keeps the usual clinical follow-up and delegates the repetitive behavioral component to the VR environment.

The main operational challenge is training the accompanying coach within the Spanish ecosystem, where this role isn’t standardized. A reasonable option is for that role to be filled by healthcare staff with recognized qualifications, supervised by the licensed psychologist responsible for the case.

Study Limitations and Caveats on Generalization

gameChange should be read with caution. The sample focused on patients with comorbid psychosis; generalizing to primary agoraphobia (without psychosis) requires specific replication. The comparator was standard treatment rather than in vivo exposure, which limits any conclusion about clinical equivalence between modalities.

The automated virtual coach works because the protocol is heavily standardized and the population was British, with its own cultural expectations around digital mental health. Acceptance among Spanish patients may differ, and it’s worth anticipating initial resistance with targeted psychoeducation.

Finally, long-term data beyond 26 weeks remain limited. Whether the effects hold at 12 or 24 months is still an open question and calls for clinical follow-up once the protocol ends.

How to Build a VR Agoraphobia Protocol in Practice

Even without replicating the full gameChange model, a psychologist in Spain can integrate VR exposure into their standard agoraphobia protocol. The typical operational sequence includes standardized initial assessment, psychoeducation on the panic and agoraphobia model, building an individualized hierarchy, and progressive VR exposure with in-person support from the psychologist.

The scenarios typically needed are: public transportation (bus, subway), supermarket and shopping mall, busy pedestrian street, open square, elevator, restaurant, crowded enclosed spaces, and being a passenger in a moving vehicle. Each scenario is graded by crowd density, duration, perceived possibility of escape, and level of ambient activity.

Transfer to real-life situations remains the ultimate success criterion. It’s worth including in vivo exposure tasks consistent with the VR hierarchy from the start and planning the timing of the transition.

The Role of the Licensed Psychologist

The licensed psychologist retains full clinical responsibility: diagnosis, treatment indication, case formulation, supervision of exposure, interim assessment, and closure. VR is a support tool that reduces logistical dependence on in vivo exposure — it is not an alternative to clinical judgment.

The psychologist’s role also includes detecting warning signs during treatment: affective decompensation, emerging suicidal ideation, traumatic reactivation, or the appearance of dissociative symptoms. No VR protocol should be run without a clear action plan for these situations.

The indication for VR should be documented in the clinical record along with its justification, the session plan, progress criteria, and discontinuation criteria. This documentation protects the psychologist from an ethical-practice standpoint and provides traceability for the process.

Perspective: Agoraphobia as a Proving Ground for Scalable VRET

The clinical interest of gameChange extends beyond agoraphobia. The protocol shows that a scalable model of VR exposure with limited psychological supervision can improve access to evidence-based treatment for disorders with high demand and insufficient supply. The natural extrapolation reaches social anxiety, GAD, specific phobias, and OCD.

For the psychologist in private practice, the practical implication is twofold. On one hand, integrating VR into their practice lets them differentiate their clinical offering and reach patients who don’t respond to imaginal exposure. On the other, it opens the door to hybrid models in which the frequency of VR sessions doesn’t depend solely on the psychologist’s calendar.

The VRET team supports onboarding with documented agoraphobia protocols, adjustable scenarios, and brief training sessions. If you want to assess how this would fit into your current protocol, you can book a demo with the team.

This article is for informational purposes for psychology professionals. It is not clinical advice for any individual case and does not replace the judgment of the licensed psychologist in charge. VRET is professional clinical-support software, not a CE-marked medical device.